Literature DB >> 8813333

Interferons and the tumor cell.

H Strander1, S Einhorn.   

Abstract

Optimal use of interferons (IFNs) for the treatment of tumor disease requires experimental work in order to precisely define IFN actions. We have pointed out three modes of such actions relevant for the antitumor efficacy exerted by IFNs: effects on apoptosis, effects on genes involved in malignant transformation and effects on angiogenesis. These are but three selected areas forming a basis for the development of optimal IFN therapy. Further experimental work, undertaken in these and additional IFN areas, is mandatory for the most effective clinical use of IFNs for the treatment of tumor disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8813333     DOI: 10.1007/bf01877207

Source DB:  PubMed          Journal:  Biotherapy        ISSN: 0921-299X


  3 in total

1.  Apoptosis-inducing factor (AIF) is targeted in IFN-α2a-induced Bid-mediated apoptosis through Bak activation in ovarian cancer cells.

Authors:  Kotaro Miyake; Joseph Bekisz; Tongmao Zhao; Christopher R Clark; Kathryn C Zoon
Journal:  Biochim Biophys Acta       Date:  2012-06-07

2.  The Cullin 3 substrate adaptor KLHL20 mediates DAPK ubiquitination to control interferon responses.

Authors:  Yu-Ru Lee; Wei-Chien Yuan; Hsuan-Chung Ho; Chun-Hau Chen; Hsiu-Ming Shih; Ruey-Hwa Chen
Journal:  EMBO J       Date:  2010-04-13       Impact factor: 11.598

3.  Interferon alpha induces nucleus-independent apoptosis by activating extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase downstream of phosphatidylinositol 3-kinase and mammalian target of rapamycin.

Authors:  Theocharis Panaretakis; Linn Hjortsberg; Katja Pokrovskaja Tamm; Ann-Charlotte Björklund; Bertrand Joseph; Dan Grandér
Journal:  Mol Biol Cell       Date:  2007-10-17       Impact factor: 4.138

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.